Biology Reference
In-Depth Information
Kaiser, J. (2011). Embryonic stem cells. Researchers mull impact of Geron's sudden exit from
field.
Science
,
334
, 1043.
Kakulas, B. A. (1999). A review of the neuropathology of human spinal cord injury with
emphasis on special features.
The Journal of Spinal Cord Medicine
,
22
, 119-124.
Keirstead, H. S., Nistor, G., Bernal, G., et al. (2005). Human embryonic stem cell-derived
oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spi-
nal cord injury.
The Journal of Neuroscience: The Official Journal of the Society for Neuroscience
,
25
, 4694-4705.
Kim, J. E., Li, S., Grandpre, T., et al. (2003). Axon regeneration in young adult mice lacking
Nogo-A/B.
Neuron
,
38
, 187-199.
Kim, J. E., Liu, B. P., Park, J. H., et al. (2004). Nogo-66 receptor prevents raphespinal and
rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Neuron
,
44
, 439-451.
Knoller, N., Auerbach, G., Fulga, V., et al. (2005). Clinical experience using incubated
autologous macrophages as a treatment for complete spinal cord injury: Phase I study
results.
Journal of Neurosurgery. Spine
,
3
, 173-181.
Kwon, B. K., Hillyer, J., & Tetzlaff, W. (2010). Translational research in spinal cord injury: A
survey of opinion from the SCI community.
Journal of Neurotrauma
,
27
, 21-33.
Lammertse, D. P., Jones, L. A., Charlifue, S. B., et al. (2012). Autologous incubated mac-
rophage therapy in acute, complete spinal cord injury: Results of the phase 2 randomized
controlled multicenter trial.
Spinal Cord
,
50
, 661-671.
Lazarov-Spiegler, O., Solomon, A. S., Zeev-Brann, A. B., et al. (1996). Transplantation of
activated macrophages overcomes central nervous system regrowth failure.
FASEB Jour-
nal: Official Publication of the Federation of American Societies for Experimental Biology
,
10
,
1296-1302.
Levine, J. M., & Reynolds, R. (1999). Activation and proliferation of endogenous oligoden-
drocyte precursor cells during ethidium bromide-induced demyelination.
Experimental
Neurology
,
160
, 333-347.
Li, S., Liu, B. P., Budel, S., et al. (2004). Blockade of Nogo-66, myelin-associated glycopro-
tein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes
axonal sprouting and recovery after spinal injury.
The Journal of Neuroscience: The Official
Journal of the Society for Neuroscience
,
24
, 10511-10520.
Li, S., & Strittmatter, S. M. (2003). Delayed systemic Nogo-66 receptor antagonist promotes
recovery from spinal cord injury.
The Journal of Neuroscience: The Official Journal of the So-
ciety for Neuroscience
,
23
, 4219-4227.
Liebscher, T., Schnell, L., Schnell, D., et al. (2005). Nogo-A antibody improves regeneration
and locomotion of spinal cord-injured rats.
Annals of Neurology
,
58
, 706-719.
Liu, B. P., Fournier, A., Grandpre, T., et al. (2002). Myelin-associated glycoprotein as a func-
tional ligand for the Nogo-66 receptor.
Science
,
297
, 1190-1193.
Lord-Fontaine, S., Yang, F., Diep, Q., et al. (2008). Local inhibition of Rho signaling by
cell-permeable recombinant protein BA-210 prevents secondary damage and promotes
functional recovery following acute spinal cord injury.
Journal of Neurotrauma
,
25
,
1309-1322.
Lu, P., Wang, Y., Graham, L., et al. (2012). Long-distance growth and connectivity of neural
stem cells after severe spinal cord injury.
Cell
,
150
, 1264-1273.
Maier, I. C., Ichiyama, R. M., Courtine, G., et al. (2009). Differential effects of anti-Nogo-A
antibody treatment and treadmill training in rats with incomplete spinal cord injury.
Brain: A Journal of Neurology
,
132
, 1426-1440.
Mayor, S. (2010). First patient enters trial to test safety of stem cells in spinal injury.
BMJ
,
341
,
c5724.
Merkler, D., Metz, G. A., Raineteau, O., et al. (2001). Locomotor recovery in spinal
cord-injured rats treated with an antibody neutralizing the myelin-associated neurite
